Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Chugai's Xeloda obtains Japanese approval for new indication in colon cancer

Dec. 18, 2007

ImClone initiates phase II clinical trial of IMC-1121B for metastatic malignant melanoma

Dec. 18, 2007

New therapeutics for cancer covered in recent patent literature

Dec. 18, 2007

Phase II data on VNP-40101M in elderly AML patients reported

Dec. 18, 2007

Signs of activity seen with CPX-351 in leukemia, myelodysplastic syndrome

Dec. 18, 2007

Japan's NHI drug reimbursement price list includes Chugai's Tarceva

Dec. 17, 2007

Chroma announces results from phase I study of cancer therapy CHR-2797

Dec. 17, 2007

Mitsubishi Tanabe Pharma reports positive preclinical data on novel tyrosine kinase inhibitor AV-412

Dec. 17, 2007

Genentech to initiate phase II clinical testing in 2008 of Hedgehog antagonist drug candidate

Dec. 17, 2007

Activity of obatoclax investigated in multiple studies

Dec. 17, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...